Navigation Links
Wound Management Technologies, Inc. Announces Strategic Plans for Revenue Growth for Year End and 2009
Date:9/11/2008

FORT WORTH, Texas, Sept. 11 /PRNewswire-FirstCall/ -- Wound Management Technologies, Inc., (OTC Bulletin Board: WNDM), announced today its strategic plans for the remainder of the year and for 2009. "The company has been focused on bringing the science and technology to the market for the first 3 quarters of the year to position CellerateRx(TM) as the number one collagen-based wound care product in the world. We have been working with several major medical groups, physicians and scientists across the US to validate our belief that CellerateRx is a 'one-of-a-kind' collagen product," stated CEO Scott Haire.

"With our patented technology and the way CellerateRx works when it is applied to an open wound, we don't believe that there is any other topical wound care product that can perform as well as CellerateRx," he went on to say. The company will present the product this week at the New Cardiovascular Horizons and Management of the Diabetic Foot & Wound Healing (NCVH) conference in New Orleans, September 10-13.

"This year we wanted to establish ourselves as the leading collagen product in the $2 billion plus US wound care market by providing science and evidence-based studies behind CellerateRx.

We believe that these efforts will enable us to strategically grow our revenue base in 2009."

The company has leveraged its internal relationships and has focused on the US nursing home market to date. In addition to extended US sales channels, the company is currently working on leads in international markets with distributors that have major interest in the CellerateRx product. The international prevalence of diabetes and its related wounds have spurred sales interests in both the US and international markets.

About Wound Management Technologies, Inc.:

Wound Management Technologies, Inc. (OTC Bulletin Board: WNDM), with its corporate headquarters in Fort Worth, Texas, markets and distributes wound care products to the healthcare market under patented technology licensed to the Company. The Company is positioned and seeks to be a leading provider of wound care products. For more information on the Company please visit the Company's Website at http://www.Celleraterx.com .

"Safe Harbor" Statement: Under The Private Securities Litigation Reform Act of 1995: The statements in the press release that relate to the company's expectations with regard to the future impact on the company's results from new products in development are "forward-looking statements," within the meaning of the Private Securities Litigation Reform Act of 1995. Since this information may contain statements that involve risk and uncertainties and are subject to change at any time, the company's actual results may differ materially from expected results. This document may contain forward-looking statements concerning the Company's operations, current and future performance and financial condition. These items involve risks and uncertainties such as product demand, market and customer acceptance, the effect of economic conditions, competition, pricing, the ability to consummate and integrate acquisitions, and other risks and uncertainties detailed in the Company's SEC filings. The Company undertakes no obligation to revise any of these statements to reflect the future circumstances or the occurrence of unanticipated events.

For Further Information:

Product Information Shareholder Relations

Cathy Bradshaw Lucy Singleton

President Secretary

954-315-9242 817-820-7080


'/>"/>
SOURCE Wound Management Technologies, Inc.
Copyright©2008 PR Newswire.
All rights reserved

Related medicine news :

1. Life-Saving News for Battlefield Soldiers & Wounded Civilians
2. LifeNet Health Establishes The Skin & Wound Allograft Institute
3. Operation Mend Offers New Hope for Wounded Warriors
4. PEAK Surgical Announces Positive Surgical Incision Wound Healing Results With the PEAK PlasmaBlade(TM)
5. Remarks by President Bush, Senator Bob Dole and Secretary Donna Shalala on Commission on Care for Americas Returning Wounded Warriors Report Implementation
6. Patients should ask surgeons about using honey to heal wounds
7. The USO and CarePages.com Help Wounded Troops Stay Connected to Their Families
8. Trends in Treatment of Americas Wounded Warriors
9. Report Release: Trends in Treatment of Americas Wounded Warriors
10. Innocoll Receives Intends to Grant Notices from the European Patent Office for Two European Patent Applications Related to Novel Wound Healing, Biosurgery and Drug Delivery Applications of its CollaRx(R) Technology
11. Randy Travis Participates in American Red Cross Holiday Card Program to Wounded Service Members
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:12/5/2016)... ... December 05, 2016 , ... Routine ... measurements are consistently correct. However, regular performance testing is often neglected because ... a solution: SmartCal™ . This innovative test substance offers a fast ...
(Date:12/4/2016)... (PRWEB) , ... December 03, 2016 , ... ... organization devoted exclusively to funding innovative lymphoma research and serving the lymphoma community ... hosted its first Swirl: A Wine Tasting Event in New York City, with ...
(Date:12/4/2016)... ... December 04, 2016 , ... "Pro3rd Displace ... animation styles with unique displacement design elements," said Christina Austin - CEO of ... Choose from a variety of design styles that include both left aligned and ...
(Date:12/2/2016)... ... December 02, 2016 , ... Lori G. Cohen and Sara ... speak at the American Conference Institute’s 21st Drug & Medical Device Litigation Conference ... Sponsor of the conference. , Cohen, who chairs the firm’s Pharmaceutical, Medical Device & ...
(Date:12/2/2016)... , ... December 02, 2016 , ... Advanced Inc., a ... has appointed Jason Bice, CPA, MBA to serve as Advanced Inc.’s Chief Financial Officer, ... Inc. , Jason brings extensive financial and operational leadership experience to Advanced Inc. ...
Breaking Medicine News(10 mins):
(Date:12/4/2016)... Johnson & Weaver, LLP announces that a class ... Biomet Holdings, Inc. (NYSE: ZBH )  securities during ... (the "Class Period"). Zimmer Biomet provides musculoskeletal healthcare ... products, such as knee and hip reconstructive products. ... , , ...
(Date:12/4/2016)... DIEGO , Dec. 3, 2016 Sickle ... by rigid, sickle-shaped red blood cells that get stuck ... severe pain, stroke, organ failure, and complications leading to ... are born with SCD, and most of them lack ... fact, the only established long-term therapy for SCD, a ...
(Date:12/4/2016)... Dec. 3, 2016  Findings from a Novartis ... CTL019, an investigational chimeric antigen receptor T cell ... young adult patients with B-cell acute lymphoblastic leukemia ... session at the 58th American Society of Hematology ... p.m.). The global Phase II study found that ...
Breaking Medicine Technology: